Dr A C C Newman (Director of Development, Wellcome Foundation)

Memoranda and attached papers, and notes of meetings, concerning the testing and marketing of a number of drugs.

Part 1/2 (February 1967 to May, 1968), key words:
Ancaris; proposed extension to Wellcome Research Laboratory, Pirbright; South African Patent Application No 66/1571; Foot and Mouth Disease vaccine; Salmonella vaccine; Marek's Disease; Non-Steroidal Anti-Inflammatory Agent (AF.983); Wander Compound HR-2073 (against Babesiasis); Agreement with Hoechst (Diacyl-di-thiosemicarbazones); Anaplasmacide Compound 356C61; Brucella abortus vaccine;

Part 2/2 (June 1968 to December 1969), key words:
Louping Ill Vaccine; Interpat; Marek's Disease vaccine; Trimethoprim; Foot and Mouth Disease vaccine; sheep dip; Rotenone; Wander compound 4A65 (Babesicide); new product procedure; collaboration with BDH Research Ltd.

1967-1969

1 file (in 2 parts) A large file split into 2 material parts.